South Jordan, Utah-based Merit adds the latest delivery system to its growing electrophysiology (EP) and cardiac rhythm ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

This Research Topic delves into the forefront of strategies and technologies designed to improve long-term outcomes for ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

A decade after bringing Transcatheter Aortic Valve Replacement (TAVR) to Alaska, doctors at Providence Alaska Medical Center ...

About 35% of people had a previous aortic or mitral valve intervention. Left ventricular ejection fraction was just under 60% ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the trial’s ...

Get Instant Summarized Text (Gist) A new transcatheter valve, the Trilogy system, has demonstrated safety and efficacy in treating aortic regurgitation, with a one-year mortality rate of 8.1% ...

Valve’s Index headset was a market leader among PC VR headsets for years, but is it still worth buying in 2025 now that it’s nearly six years old? Read on for our no-nonsense recommendation.